Clinical Trials Browser

Phase 1 × Rectal Neoplasms × durvalumab × Clear all

NCT04108481 2025-03-28

iRE-C

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms